Galera Therapeutics, Inc. ( GRTX) - Key Metrics
GRTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$3.26 | -$1.77 | -$1.77 |
| 2025Q4 | $0 | $310.86 | -$4.54 | -$4.54 |
| 2025Q3 | $0 | -$2.82 | -$1.54 | -$1.54 |
| 2025Q2 | $0 | -$2.18 | $4.54 | $4.54 |
| 2025Q1 | $0 | -$5.83 | -$8.19 | -$8.19 |
GRTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.69 |
| 2025Q4 | 0% | 0.00 |
| 2025Q3 | 0% | -0.31 |
| 2025Q2 | 0% | -0.62 |
| 2025Q1 | 0% | -0.26 |
GRTX
Price: $16.28
52 week price:
Earnings Per Share: 120.44 USD
P/E Ratio: 0.14
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 52746
Market Capitalization: 3.4 billion